Literature DB >> 19643357

Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.

Roy S Small1, William Wickemeyer, Robin Germany, Bobbi Hoppe, John Andrulli, Peter A Brady, Melody Labeau, Jodi Koehler, Shantanu Sarkar, Douglas A Hettrick, W H Wilson Tang.   

Abstract

BACKGROUND: Acute decreases in intrathoracic impedance monitoring have been shown to precede heart failure hospitalization in a limited population of heart failure patients. We evaluated the relationship between changes in intrathoracic impedance with hospitalizations associated with acute decompensated heart failure (ADHF) in patients with cardiac resynchronization therapy plus defibrillator (CRT-D) devices. METHODS AND
RESULTS: The study enrolled 326 heart failure patients who had received CRT-D with impedance-monitoring capabilities (InSync Sentry, Medtronic). The date and duration of ADHF hospitalizations were retrospectively identified before device interrogation to obtain device diagnostic information. During 333 +/- 96 days of device monitoring, 228 patients experienced 540 intrathoracic impedance fluid index threshold crossings events (TCE) at the nominal threshold value (60 Omega. days). During the initial 4-month evaluation period, 17 subjects experienced 22 ADHF hospitalizations. In the subsequent monitoring period (206 +/- 95 days), 18 patients experienced 24 hospitalizations. The occurrence of TCEs during the monitoring period was independently correlated with the subsequent rate of ADHF hospitalization such that each TCE event during the risk stratification period was associated with a 35% increased risk for ADHF hospitalization in the remaining study period (P = .001). Poisson regression indicated that the subgroup of patients with an annual average rate of more than 3 threshold crossings per year during the monitoring period were significantly more likely to be hospitalized for ADHF than those patients with no TCE during the monitoring period (0.76 [0.20-1.325] vs. 0.14 [0.05-0.23] hospitalizations/subject/y [95%CI]; P = .02). Likewise, Kaplan-Meier analysis revealed that subsets of patients with more than 3 TCEs per year or with more than 30 days per year above threshold during the risk stratification period had significantly higher rates of ADHF hospitalization during the post risk stratification period than subjects with no TCE events, respectively.
CONCLUSIONS: In this multicenter retrospective cohort study, serial decreases in intrathoracic impedance sufficient to generate a fluid index threshold crossing as well as the net duration that the index remained above threshold during a 4-month monitoring period were associated with subsequent risk of ADHF hospitalization.

Entities:  

Mesh:

Year:  2009        PMID: 19643357     DOI: 10.1016/j.cardfail.2009.01.012

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  32 in total

1.  Clinically meaningful change estimates for the six-minute walk test and daily activity in individuals with chronic heart failure.

Authors:  Michael J Shoemaker; Amy B Curtis; Eric Vangsnes; Michael G Dickinson
Journal:  Cardiopulm Phys Ther J       Date:  2013-09

2.  Predictive impact of the decreasing rate of intrathoracic impedance in worsening chronic heart failure.

Authors:  Shinya Yamada; Hitoshi Suzuki; Yoshiyuki Kamiyama; Shu-ichi Saitoh; Yasuchika Takeishi
Journal:  J Interv Card Electrophysiol       Date:  2014-03-22       Impact factor: 1.900

Review 3.  Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices.

Authors:  Philip B Adamson
Journal:  Curr Heart Fail Rep       Date:  2009-12

4.  A mixed methods study of symptom perception in patients with chronic heart failure.

Authors:  Barbara Riegel; Victoria Vaughan Dickson; Christopher S Lee; Marguerite Daus; Julia Hill; Elliane Irani; Solim Lee; Joyce W Wald; Stephen T Moelter; Lisa Rathman; Megan Streur; Foster Osei Baah; Linda Ruppert; Daniel R Schwartz; Alfred Bove
Journal:  Heart Lung       Date:  2018-01-03       Impact factor: 2.210

5.  Influence of lung volume, fluid and capillary recruitment during positional changes and exercise on thoracic impedance in heart failure.

Authors:  Chul-Ho Kim; Matthew A Fuglestad; Maile L Ceridon Richert; Win K Shen; Bruce D Johnson
Journal:  Respir Physiol Neurobiol       Date:  2014-08-14       Impact factor: 1.931

Review 6.  Implantable devices for heart failure monitoring and therapy.

Authors:  Maxwell Eyram Afari; Wajih Syed; Lana Tsao
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

7.  Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance.

Authors:  Michael R Zile; Vinod Sharma; James W Johnson; Eduardo N Warman; Catalin F Baicu; Tom D Bennett
Journal:  Circ Heart Fail       Date:  2015-12-23       Impact factor: 8.790

Review 8.  Remote Monitoring in Heart Failure: the Current State.

Authors:  Rajeev C Mohan; J Thomas Heywood; Roy S Small
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-03

9.  Device monitoring strategies in acute heart failure syndromes.

Authors:  Michael A Samara; W H Wilson Tang
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

10.  Update on device technologies for monitoring heart failure.

Authors:  Bharat Singh; Stuart D Russell; Alan Cheng
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.